Journals 2023
Publications menu
        Combination of quinoxaline with pentamethinium system: Mitochondrial staining and targeting.        
                  Bioorganic Chemistry.                
                  2023,
                
                              141,
                  
                              106816,
                          
                  ISSN: 0045-2068,
                
                
                              PMID: 37716274,                          
                
                          
        
      
    
        Identification of novel dithiocarbamate-copper complexes targeting p97/NPL4 pathway in cancer cells.        
                  European Journal of Medicinal Chemistry.                
                  2023,
                
                              261,
                  
                              115790,
                          
                  ISSN: 0223-5234 ,
                
                
                              PMID: 37690264,                          
                
                          
        
      
    
        A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma.        
                  Carcinogenesis.                
                  2023,
                
                          
                                  
                  ISSN: 0143-3334,
                
                
                              PMID: 37670727,                          
                
        
        
      
    
        Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor.        
                  Molecular Cancer Therapeutics.                
                  2023,
                
                              22(12),
                  
                              1390-1403,
                          
                  ISSN: 1535-7163,
                
                
                              PMID: 37616542,                          
                
        
        
      
    
        TET protein inhibitors: Potential and limitations.        
                  Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie.                
                  2023,
                
                              166,
                  
                              115324,
                          
                  ISSN: 0753-3322,
                
                
                              PMID: 37598475.                          
                
                          
        
      
    
        Circulating tumor cell-derived preclinical models: current status and future perspectives.        
                  Cell Death & Disease.                
                  2023,
                
                              14(8),
                  
                              530,
                          
                  ISSN: 2041-4889,
                
                
                              PMID: 37591867,                          
                
                          
        
      
    
        The adenylate cyclase toxin RTX domain follows a series templated folding mechanism with implications for toxin activity.        
                  The Journal of Biological Chemistry.                
                  2023,
                
                              299(9),
                  
                              105150,
                          
                  ISSN: 0021-9258,
                
                
                              PMID: 37567473,                          
                
                          
        
      
     
               
               
               
               
               
               
               
               
              